The roles of programmed death ligand 1 in virus-associated cancers

Morvarid Golrokh Mofrad1, Donya Taghizadeh Maleki2, Ebrahim Faghihloo2

  • 1Human Viral Vaccine Department, Razi Vaccine & Serum Research Institute, Agricultural Research, Education & Extension Organization (AREEO), Karaj, Iran.

Insights

Viruses can alter the expression of programmed death ligand 1 (PD-L1), a key immune checkpoint. This viral manipulation of PD-L1 may contribute to uncontrolled cell growth and tumor formation in virus-associated cancers.

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Programmed death ligand 1 (PD-L1), also known as CD274 or B7-H1, is a surface glycoprotein that suppresses T-cell responses.
  • PD-L1 binding to PD-1 inhibits T-cell proliferation and promotes regulatory T-cell survival, thereby hindering the immune system's ability to eliminate cancer cells.
  • Viruses employ diverse strategies to evade immune surveillance, including modulation of host gene expression and protein function, which can impact PD-L1 levels.

Purpose of the Study:

  • To investigate the effect of various tumorigenic viruses on the expression of PD-L1.
  • To evaluate the correlation between viral presence and PD-L1 expression.
  • To explore the potential of the PD-1/PD-L1 pathway as a therapeutic target in virus-associated cancers.

Main Methods:

  • Literature review and survey of existing studies.
  • Analysis of the association between specific viruses and PD-L1 expression.
  • Identification of tumorigenic viruses including HPV, EBV, HTLV-1, HBV, and HCV.

Main Results:

  • Most studies indicate that viral infections lead to the overexpression of PD-L1.
  • Viral functions appear to be a significant factor in the upregulation of PD-L1.
  • A correlation between the presence of certain viruses and elevated PD-L1 expression was observed.

Conclusions:

  • Viral infections can significantly influence PD-L1 expression, potentially contributing to tumor development.
  • The PD-1/PD-L1 pathway is implicated in the pathogenesis of virus-associated cancers.
  • Further research is warranted to fully elucidate the role of PD-1/PD-L1 in these cancers and its potential for anti-PD-L1 therapies.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K